Kayne Anderson Rudnick Investment Management LLC Crispr Therapeutics Ag Transaction History
Kayne Anderson Rudnick Investment Management LLC
- $42 Billion
- Q4 2024
A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 14 shares of CRSP stock, worth $543. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 14
-0.0%
Holding current value
$543
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
485Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$348 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$339 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$148 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$108 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$107 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.03B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....